Abstracts now open

At least 2 members from the scientific committee will review and score each abstract. Applications close 1 June, applicants will be informed of the outcome by the 30 June 2026.

Abstract Guidelines

The authors certify that the work described in this abstract is original and has been conducted by the listed authors. The abstract has not been previously published, presented, or submitted for consideration at any other scientific meeting.

Submissions should explicitly address issues related to access to ear and hearing care, particularly in underserved or resource-limited settings

The submission format for structured abstracts includes:

Presenting Author Information:

Co-Authors Information:

Abstract Title:

Preferred presentation type: Oral / Poster / Either

Structured Scientific Abstract Text: Max 300 words (Background / Methods / Results / Conclusion)

Conflict of Interest

Funding:

Declaration:

Consent:

Under the following Category:

  1. Hearing Loss Across the Lifespan
  2. Technology in Hearing Care
  3. Noise-Induced Hearing Loss
  4. Stigma
  5. Family/ Community Empowerment
  6. Epidemiology/Advocacy
  7. Training/Education
  8. Best Practices

The submission format for non-scientific abstracts;

Presenter Information:

Title:

Preferred presentation type: Oral / Poster / Either

Under the category

Lived experiences /Personal stories

Unstructured Abstract

Text: Max 300 words (Background / context, the journey (agency, coping, technical/rehabilitation/education/ social support), Key takeaways/ call to action)

Abstracts are submitted online by registering and logging into the CGHH member portal. Click here to create a profile

 

“Funding for this conference was made possible in part by 1R13DC022790-01 from National Institute of Communication and Other Disorders. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.”